References
- Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF an related procedures. Hum Reprod 1992; 7: 320–7.
- Phelps JY, Levine AS, Hickman TN, Zacur HA, Wallach EE, Hinton EL. Day 4 estradiol levels predict pregnancy inwomen undergoing controlled ovarian hyperstimulation for IVF. Fert Steril 1998; 69: 1015–9.
- Meyer WR, Beyler SA, Baker ST, Somkuti SG, Lowden DA, Grainger D. Value of estradiol response after human chorionic gonadotrophin administration in predicting in vitro fertilization success. Fert Steril 1999; 72: 542–5.
- Good RG, Moyer DL. Estrogen-progesterone relationships in the development of the secretory endometrium. Fert Steril 1988; 19: 37–49.
- Toner JP, Hassiakos DK, Muasher SJ, Hsiu JG, Jones HWJ. Endometrial receptivities after leuprolide suppression and gonadotrophin stimulaion; histology, steroid receptor concentrations, and implantation rates. Ann NY Acad Sci 1991; 622: 220–9.
- Meyer WR, Novotny DB, Fritz MA, Beyler SA, Wolf LJ, Lessey BA. Effect of exogenous gonadotropins on endometrial maturation in oocyte donors. Fert Steril 1999; 71: 109–14.
- Chenette PE, Sauer MV Paulson RJ. Very high serum oestradiol levels are not detrimental to clinical outcome of in vitro fertilisation. Fert Steril 1990; 54: 858–63.
- Hanning RVJ, Boeehlein LM, Carlson IH, Zweibel WJ. Diagnosis specific serum 17-oestradiol (E2) upper limits for treatment with menotrophins using 125I direct E2 assay. Fert Steril 1984; 42: 882–6.
- Simon C, Cano F, Valbuena D. Clinical evidence for the detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995; 10: 2432–7.
- Maragalioth EJ, Taney FH, Cooper GW, Scholl GM, Rosenfeld DL. Correlation between serum oestradiol level on day of HCG and speed of embryo development in in vitro fertilisation. Hum Reprod 1993; 8: 732–4.
- Brinsden PR, Wada SL, Tan A, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimu-lation syndrome. Br J Obstet Gynaecol 1995; 102: 767–72.
- Murad NM. Ultrasound or ultrasound and hormonal determinations for in vitro fertilization monitoring. Int J Gynaecol Obstet 1998; 63: 271–6.
- Wikland M, Borg J, Hamberger L, Svalander P. Simplification of IVF; minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum Reprod 1994; 9: 1430–6.
- Sher G, Zouves C, Feinman M, Maassarani G. ‘Prolonged coasting’: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod 1995; 10: 3107–9.
- Scwartz M, Jewelwicz R, Dyrenfurth I, Troppe P, Van de Wiele RL. The use of human menopausal and chorionic gonadotrophins for the induction of ovulation: sixteen years experience at the Sloane Hospital for Women. Am J Obstet Gynecol 1980; 138: 801–2.
- Sharma V, Riddle A, Mason BA, Pampiglione J, Campbell S. An analysis of factors influencing the establishment of a clinical pregnancy in an ultrasound based ambulatory in vitro fertilisation program. Fert Steril 1988; 49: 468–9.
- Nargund G, Waterstone J, Bland J, Phillips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural cycle (unstimulated) IVF cycles. Hum Reprod 2001; 16: 259–62.